http://www.zibb.com/all/theme/cq/Bristol+Myers+Squibb+Company Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Tue, 24 Nov 2009 08:00:00 GMTTue, 24 Nov 2009 08:00:00 GMT608831http://www.zibb.com/all/theme/cq/Bristol+Myers+Squibb+Company http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.laboratorytalk.com/news/asl/asl108.htmlAsterand has extended a collaboration to give Bristol-Myers Squibb access to its products and services for up to three years.http://www.laboratorytalk.com/news/asl/asl108.htmlBristol Myers Squibb CompanyTue, 24 Nov 2009 08:00:00 GMThttp://www.zibb.com/article/5688949/Bristol+Myers+Squibb+Up+Since+SmarTrend+s+Buy+RecommendationSmarTrend, our proprietary pattern recognition system, called an Uptrend for Bristol-Myers Squibb (NYSE:BMY) on July 30, 2009 at $21.76. Since then, Bristol-Myers Squibb has returned 15.1% as of today's recent price of $25.04. Want to profit from these alerts? Go to www.mysmartrend.com now for ahttp://www.zibb.com/article/5688949/Bristol+Myers+Squibb+Up+Since+SmarTrend+s+Buy+RecommendationBristol Myers Squibb CompanyTue, 24 Nov 2009 01:34:28 GMThttp://finance.yahoo.com/news/BristolMyers-extends-apf-1935439253.html?x=0&.v=1NEW YORK (AP) -- Drugmaker Bristol-Myers Squibb Co. and Asterand PLC are extending a research collaboration for up to three years, Asterand said Monday.Asterand, with officeshttp://finance.yahoo.com/news/BristolMyers-extends-apf-1935439253.html?x=0&.v=1Bristol Myers Squibb CompanyMon, 23 Nov 2009 16:19:48 GMThttp://www.businessweekly.co.uk/2009112335880/life-sciences/asteran-extends-collaboration-with-bristol-myers-squibb.htmlAsterand, the Cambridge company specialising in human tissue for drug discovery and development has extended its collaboration with Bristol-Myers Squibb for access to Asterand's products and services for up to three years.http://www.businessweekly.co.uk/2009112335880/life-sciences/asteran-extends-collaboration-with-bristol-myers-squibb.htmlBristol Myers Squibb CompanyMon, 23 Nov 2009 13:03:02 GMThttp://www.biospace.com/news_story.aspx?StoryID=163628&full=1PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY - News) and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S.http://www.biospace.com/news_story.aspx?StoryID=163628&full=1Bristol Myers Squibb CompanyMon, 23 Nov 2009 12:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=10822-Completes Major Phase in Company’s BioPharma Transformation -Provides Bristol-Myers Squibb Shareholders an Option for a Tax-Free Exchange -Expected to be Accretive to EPS Beginning in 2010 -Reflects Strength and Sustainability of BioPharhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=10822Bristol Myers Squibb CompanyTue, 17 Nov 2009 01:00:00 GMThttp://www.fool.com/investing/dividends-income/2009/11/11/dream-stocks-for-dividend-investors.aspxInvestors are always hunting for the next big stock -- the dream stock whose price increases several times over when the market finally discovers it. It's easy to look back and discover the 10 best stocks of the past decade.http://www.fool.com/investing/dividends-income/2009/11/11/dream-stocks-for-dividend-investors.aspxBristol Myers Squibb CompanyWed, 11 Nov 2009 17:07:04 GMThttp://www.drugstorenews.com/story.aspx?id=122139Drug maker Bristol-Myers Squibb will work with a private biotech company to develop a biotech drug in mid-stage clinical trials for treating rheumatoid arthritis.http://www.drugstorenews.com/story.aspx?id=122139Bristol Myers Squibb CompanyWed, 11 Nov 2009 14:40:00 GMThttp://seattle.bizjournals.com/seattle/stories/2009/11/09/daily15.html?ana=yfcpcAlder Biopharmaceuticals and Bristol-Myers Squibb sign deal worth up to $1Bhttp://seattle.bizjournals.com/seattle/stories/2009/11/09/daily15.html?ana=yfcpcBristol Myers Squibb CompanyTue, 10 Nov 2009 17:05:18 GMThttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3562321&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=3562321&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2303731850%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directoryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3562321&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=3562321&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2303731850%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBristol Myers Squibb CompanyMon, 02 Nov 2009 06:55:24 GMThttp://seekingalpha.com/article/168319-bristol-myers-squibb-co-q3-2009-earnings-call-transcript?source=feedBristol-Myers Squibb Co.(BMY)Q3 2009 Earnings CallOctober 22, 2009 10:30 am ET<ahttp://seekingalpha.com/article/168319-bristol-myers-squibb-co-q3-2009-earnings-call-transcript?source=feedBristol Myers Squibb CompanyThu, 22 Oct 2009 20:50:20 GMThttp://www.rttnews.com/Content/QuickFacts.aspx?Node=B1&Id=1101554%20&Category=Quick%20FactsRTTNews delivers all the important global financial news, Market analysis, Economics, stock alerts,forex and any news that may impact individual stocks,specific commodities, currencies and markets as a wholehttp://www.rttnews.com/Content/QuickFacts.aspx?Node=B1&Id=1101554%20&Category=Quick%20FactsBristol Myers Squibb CompanyThu, 22 Oct 2009 12:11:44 GMThttp://www.bloomberg.com/apps/news?pid=20601103&sid=a2Qi4a8CN.8EThe worldwide pharmaceutical market will grow 4 percent to 6 percent next year, exceeding $825 billion, as more Americans get health insurance to pay for their prescriptions, according to a report from [bn:WBTKR=RX:US] IMS Health Inc [].http://www.bloomberg.com/apps/news?pid=20601103&sid=a2Qi4a8CN.8EBristol Myers Squibb CompanyThu, 08 Oct 2009 05:07:25 GMThttp://www.bloggingstocks.com/2009/09/23/its-still-a-good-time-to-buy-bmy/Filed under: Bristol-Myers Squibb (BMY), Stocks to Buy<img vspace="4" hspace="4" border="1" align="right"http://www.bloggingstocks.com/2009/09/23/its-still-a-good-time-to-buy-bmy/Bristol Myers Squibb CompanyWed, 23 Sep 2009 22:00:00 GMThttp://www.pharmaceutical-business-review.com/news/rexahn_teva_agree_to_close_on_license_agreement_090917Rexahn Pharmaceuticals (Rexahn) has reached an agreement to close on its previously announced licensing and stock purchase agreements with Teva Pharmaceutical (Teva) for the development of its novel anti-cancer compound, RX-3117.http://www.pharmaceutical-business-review.com/news/rexahn_teva_agree_to_close_on_license_agreement_090917Bristol Myers Squibb CompanyThu, 17 Sep 2009 00:00:00 GMThttp://www.reuters.com/article/rbssHealthcareNews/idUST26859020090916* To pay $160 mln for painkiller Tempra, other brands * To pay $150 million for 98 pct of Bristol Indonesia * To use Bristol Indonesia's sales network and plant TOKYO, Sept 16 (Reuters) - Taishohttp://www.reuters.com/article/rbssHealthcareNews/idUST26859020090916Bristol Myers Squibb CompanyWed, 16 Sep 2009 04:36:20 GMThttp://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/08-30-2009/0005084927&EDATE=PARIS, and PRINCETON, N.J., Aug. 30 /PRNewswire/ -- Today, the OASIS study group will present initial results of the CURRENT-OASIS 7 clinical trial at the European Society of Cardiology congress in Barcelona.http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/08-30-2009/0005084927&EDATE=Bristol Myers Squibb CompanySun, 30 Aug 2009 06:00:00 GMThttp://www.pharmamanufacturing.com/industrynews/2009/139.html?CMP=ILC-rssA US court granted preliminary approval to a $125-million settlement reached in a shareholder lawsuit against Bristol-Myers Squibb regarding the company's attempts to resolve a patent dispute with Apotex over Plavix (clopidogrel), according to court documents.http://www.pharmamanufacturing.com/industrynews/2009/139.html?CMP=ILC-rssBristol Myers Squibb CompanyWed, 19 Aug 2009 07:00:59 GMThttp://pubs.acs.org/cen/news/87/i30/8730notw6.htmlA member supported weekly magazine of the American Chemical Society, Chemical And Engineering News covers all the news of the chemical world including science and technology, government and policy, and businesshttp://pubs.acs.org/cen/news/87/i30/8730notw6.htmlBristol Myers Squibb CompanyThu, 23 Jul 2009 14:20:00 GMThttp://www.canadianbusiness.com/markets/headline_news/article.jsp?content=b225195129&utm_source=markets&utm_medium=rssNEW YORK - Drugmaker Bristol-Myers Squibb Co. said Wednesday it is buying Medarex Inc. for about US$http://www.canadianbusiness.com/markets/headline_news/article.jsp?content=b225195129&utm_source=markets&utm_medium=rssBristol Myers Squibb CompanyThu, 23 Jul 2009 01:07:00 GMThttp://www.brandweek.com/bw/content_display/news-and-features/packaged-goods/e3i5f3b44e890b8e56ff852e93c9a53876bThe global pharma company spends $420 million annually in measured media.<ahttp://www.brandweek.com/bw/content_display/news-and-features/packaged-goods/e3i5f3b44e890b8e56ff852e93c9a53876bBristol Myers Squibb CompanyTue, 30 Jun 2009 16:04:00 GMThttp://www.adweek.com/aw/content_display/news/e3i5f3b44e890b8e56f06f8fa21c27ec062Advertising industry information from Adweek. Read inside stories on advertising, creative, and client - agency relationships.http://www.adweek.com/aw/content_display/news/e3i5f3b44e890b8e56f06f8fa21c27ec062Bristol Myers Squibb CompanyTue, 30 Jun 2009 15:36:00 GMThttp://www.mediaweek.com/mw/content_display/news/media-agencies-research/e3i5f3b44e890b8e56f9ea7e6c1f9d9ff2dBristol-Myers Squibb has awarded its media assignment to Publicis Groupe's MediaVest after a review, the client has confirmed.<img src="http://feedads.g.doubleclick.net/~a/acWq9cwKHS1Q9UQoj93ASEPcDKU/0/di" border="0"http://www.mediaweek.com/mw/content_display/news/media-agencies-research/e3i5f3b44e890b8e56f9ea7e6c1f9d9ff2dBristol Myers Squibb CompanyTue, 30 Jun 2009 05:25:00 GMThttp://www.genengnews.com/news/bnitem.aspx?name=52843995Bristol-Myers Squibb (BMS) is initially paying Ensemble Discovery $5 million to discover and develop drug candidates against up to eight targets. Ensemble will receive another $7.5http://www.genengnews.com/news/bnitem.aspx?name=52843995Bristol Myers Squibb CompanyWed, 15 Apr 2009 00:00:00 GMThttp://contractservices.pharmaceutical-business-review.com/news/bristol_myers_squibb_extends_us_agreement_with_otsuka_090409In addition, the companies have established oncology collaboration for two Bristol-Myers Squibb products - Sprycel (dasatinib) and Ixempra (ixabepilone). Under terms of the agreement Bristol-Myers Squibb will pay Otsuka an up-front cash payment of $400 million.http://contractservices.pharmaceutical-business-review.com/news/bristol_myers_squibb_extends_us_agreement_with_otsuka_090409Bristol Myers Squibb CompanyThu, 09 Apr 2009 03:32:40 GMT